Photo: Amylyx Pharmaceuticals The Food and Drug Administration has approved a new experimental treatment for ALS, a very rare neurological disease for which there is no cure and limited treatment options. Relyvrio—known previously as AMX0035—was given the OK by the FDA on Thursday, following a recommendation from the FDA's advisory …
Read More »FDA Approves New ALS Drug Relyvrio, Which Aims to Slow Disease Progression
/relyvrio-credit-Amylyx-Pharmaceuticals-d5ab86a7fdf84d65b8f54eed10a94ee8.jpg)